JP2020514419A5 - - Google Patents

Download PDF

Info

Publication number
JP2020514419A5
JP2020514419A5 JP2020500010A JP2020500010A JP2020514419A5 JP 2020514419 A5 JP2020514419 A5 JP 2020514419A5 JP 2020500010 A JP2020500010 A JP 2020500010A JP 2020500010 A JP2020500010 A JP 2020500010A JP 2020514419 A5 JP2020514419 A5 JP 2020514419A5
Authority
JP
Japan
Prior art keywords
cancer
alkyl
substituted
alkenyl
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2020500010A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020514419A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/022510 external-priority patent/WO2018170179A1/en
Publication of JP2020514419A publication Critical patent/JP2020514419A/ja
Publication of JP2020514419A5 publication Critical patent/JP2020514419A5/ja
Ceased legal-status Critical Current

Links

JP2020500010A 2017-03-15 2018-03-14 ベンズアゼピン化合物、そのコンジュゲート及び使用 Ceased JP2020514419A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762471886P 2017-03-15 2017-03-15
US62/471,886 2017-03-15
US201762573630P 2017-10-17 2017-10-17
US62/573,630 2017-10-17
US201862622780P 2018-01-26 2018-01-26
US62/622,780 2018-01-26
PCT/US2018/022510 WO2018170179A1 (en) 2017-03-15 2018-03-14 Benzazepine compounds, conjugates, and uses thereof

Publications (2)

Publication Number Publication Date
JP2020514419A JP2020514419A (ja) 2020-05-21
JP2020514419A5 true JP2020514419A5 (cg-RX-API-DMAC10.html) 2021-04-30

Family

ID=63523998

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020500010A Ceased JP2020514419A (ja) 2017-03-15 2018-03-14 ベンズアゼピン化合物、そのコンジュゲート及び使用

Country Status (16)

Country Link
US (5) US10239862B2 (cg-RX-API-DMAC10.html)
EP (2) EP3595668B1 (cg-RX-API-DMAC10.html)
JP (1) JP2020514419A (cg-RX-API-DMAC10.html)
KR (1) KR20200031560A (cg-RX-API-DMAC10.html)
CN (1) CN110612104A (cg-RX-API-DMAC10.html)
AU (1) AU2018236272B2 (cg-RX-API-DMAC10.html)
BR (1) BR112019019116A2 (cg-RX-API-DMAC10.html)
CA (1) CA3055652A1 (cg-RX-API-DMAC10.html)
DK (1) DK3595668T3 (cg-RX-API-DMAC10.html)
ES (1) ES2894731T3 (cg-RX-API-DMAC10.html)
HU (1) HUE056427T2 (cg-RX-API-DMAC10.html)
IL (1) IL269283B2 (cg-RX-API-DMAC10.html)
MX (1) MX2019010804A (cg-RX-API-DMAC10.html)
PT (1) PT3595668T (cg-RX-API-DMAC10.html)
SG (5) SG10202110183VA (cg-RX-API-DMAC10.html)
WO (1) WO2018170179A1 (cg-RX-API-DMAC10.html)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3464274B1 (en) * 2016-05-23 2020-05-27 H. Hoffnabb-La Roche Ag Benzazepine dicarboxamide compounds with secondary amide function
BR112019000071A2 (pt) 2016-07-07 2019-07-02 Bolt Biotherapeutics Inc conjugados adjuvantes de anticorpo
AU2018236272B2 (en) 2017-03-15 2022-03-31 Silverback Therapeutics, Inc. Benzazepine compounds, conjugates, and uses thereof
CA3084667A1 (en) * 2017-12-15 2019-06-20 Silverback Therapeutics, Inc. Antibody construct-drug conjugate for the treatment of hepatitis
US20210154316A1 (en) 2018-05-17 2021-05-27 Bolt Biotherapeutics, Inc. Immunoconjugates
BR112020025287A2 (pt) 2018-06-25 2021-03-09 University Of Washington Projeto de novo de miméticos de interleucina potentes e seletivos
EP3849971A2 (en) * 2018-09-12 2021-07-21 Silverback Therapeutics, Inc. Substituted benzazepine compounds, conjugates, and uses thereof
SG11202101980VA (en) * 2018-09-12 2021-03-30 Silverback Therapeutics Inc Methods and composition for the treatment of disease with immune stimulatory conjugates
WO2020056194A1 (en) * 2018-09-12 2020-03-19 Silverback Therapeutics, Inc. Benzazepine compounds, conjugates, and uses thereof
JP2022511390A (ja) 2018-11-20 2022-01-31 ユニバーシティ オブ ワシントン 分割インターロイキン模倣体およびその使用
EP3937984A1 (en) 2019-03-15 2022-01-19 Bolt Biotherapeutics, Inc. Immunoconjugates targeting her2
US12617866B2 (en) 2019-05-08 2026-05-05 Memorial Sloan Kettering Cancer Center Humanized antibodies to mucin-16 and methods of use thereof
EP3983080A1 (en) 2019-06-13 2022-04-20 Bolt Biotherapeutics, Inc. Macromolecule-supported aminobenzazepine compounds
JP2022537158A (ja) * 2019-06-13 2022-08-24 ボルト バイオセラピューティクス、インコーポレーテッド アミノベンズアゼピン化合物、イムノコンジュゲート、及びそれらの使用
MX2021015533A (es) 2019-06-19 2022-02-10 Silverback Therapeutics Inc Anticuerpos anti-mesotelina e inmunoconjugados de los mismos.
JP2022544543A (ja) 2019-08-15 2022-10-19 シルバーバック セラピューティックス インコーポレイテッド ベンザゼピンコンジュゲートの製剤およびその使用
EP4038053A1 (en) * 2019-09-30 2022-08-10 Bolt Biotherapeutics, Inc. Amide-linked, aminobenzazepine immunoconjugates, and uses thereof
WO2021067644A1 (en) * 2019-10-01 2021-04-08 Silverback Therapeutics, Inc. Combination therapy with immune stimulatory conjugates
US20210130473A1 (en) 2019-10-09 2021-05-06 Silverback Therapeutics, Inc. TGFßR1 INHIBITOR-ASGR ANTIBODY CONJUGATES AND USES THEREOF
WO2021072330A1 (en) 2019-10-09 2021-04-15 Silverback Therapeutics, Inc. Galnac-tgfbr1 inhibitor conjugates for the treatment of liver diseases
US11554999B2 (en) 2019-11-15 2023-01-17 Goodrich Corporation Inflation systems for evacuation slides and life rafts
US11179473B2 (en) 2020-02-21 2021-11-23 Silverback Therapeutics, Inc. Nectin-4 antibody conjugates and uses thereof
EP4121449A2 (en) 2020-03-16 2023-01-25 Neoleukin Therapeutics, Inc. Interleukin-2 receptor beta (il-2rb) binding polypeptides
WO2021207207A2 (en) 2020-04-07 2021-10-14 Neoleukin Therapeutics, Inc. De novo protein decoys of angiotensin-converting enzyme 2 (ace2)
KR20230047361A (ko) 2020-07-01 2023-04-07 아르스 파마슈티컬스 인크. 항-asgr1 항체 접합체 및 이의 용도
CA3187837A1 (en) * 2020-08-04 2022-02-10 Exelixis, Inc. Cd47 binding agents and uses thereof
CA3187850A1 (en) 2020-08-04 2022-02-10 Bryan Glaser Pd-l1 binding agents and uses thereof
MX2023001679A (es) * 2020-08-13 2023-02-22 Bolt Biotherapeutics Inc Inmunoconjugados de pirazolazepina y usos de estos.
JP2023552790A (ja) * 2020-12-11 2023-12-19 ボルト バイオセラピューティクス、インコーポレーテッド 抗pd-l1イムノコンジュゲート、及びそれらの使用
US20220195066A1 (en) * 2020-12-11 2022-06-23 Bolt Biotherapeutics, Inc. Anti-cea immunoconjugates, and uses thereof
CA3200056A1 (en) 2020-12-11 2022-06-16 Shelley Erin ACKERMAN Anti-her2 immunoconjugates, and uses thereof
JP7844499B2 (ja) * 2021-03-08 2026-04-13 ジーンクアンタム ヘルスケア (スーチョウ) シーオー., エルティーディー. 抗体-免疫アゴニストコンジュゲート及びその使用
WO2022217022A1 (en) 2021-04-10 2022-10-13 Profoundbio Us Co. Folr1 binding agents, conjugates thereof and methods of using the same
CA3216459A1 (en) 2021-04-23 2022-10-27 Profoundbio Us Co. Anti-cd70 antibodies, conjugates thereof and methods of using the same
EP4342884A4 (en) * 2021-05-19 2025-10-29 Shanghai De Novo Pharmatech Co Ltd Compound containing nitrogen, conjugate containing said compound, and associated use
TW202320857A (zh) 2021-07-06 2023-06-01 美商普方生物製藥美國公司 連接子、藥物連接子及其結合物及其使用方法
WO2023044318A2 (en) 2021-09-15 2023-03-23 Neoleukin Therapeutics, Inc. Interleukin-2 receptor βeta (il-2rβ) binding polypeptides
WO2023154318A1 (en) * 2022-02-09 2023-08-17 Bolt Biotherapeutics, Inc. Anti-tr0p2, aminobenzazepine immunoconjugates, and uses thereof
JP2025537044A (ja) * 2022-09-30 2025-11-13 シャンハイ ドーァ ノボ ファーマテック カンパニー,リミティド ベンザゼピン誘導体、それを含む複合体およびその応用
WO2025027529A1 (en) 2023-07-31 2025-02-06 Advesya Anti-il-1rap antibody drug conjugates and methods of use thereof
AR133955A1 (es) 2023-09-26 2025-11-19 Profoundbio Us Co Agentes de unión a ptk7, conjugados de éstos y métodos de uso de los mismos
TW202530255A (zh) 2023-12-15 2025-08-01 法商亞維西亞有限公司 抗il-1rap結合結構域及其抗體-藥物偶聯物
TW202547866A (zh) 2024-01-10 2025-12-16 丹麥商珍美寶股份有限公司 Slitrk6結合劑、其共軛物及使用彼之方法
WO2025181219A1 (en) 2024-02-29 2025-09-04 Genmab A/S Egfr and c-met bispecific binding agents, conjugates thereof and methods of using the same
TW202547884A (zh) * 2024-03-15 2025-12-16 美商艾爾維克醫療公司 Muc16/napi-2b抗體及使用方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
KR100477070B1 (ko) 1994-03-25 2006-04-21 이소테크니카 인코포레이티드 중수소화작용에의한의약품의효능강화법
US6130217A (en) * 1995-09-20 2000-10-10 Pfizer Inc Compounds enhancing antitumor activity of other cytotoxic agents
DK0825186T3 (da) 1996-08-16 2002-07-22 Pfizer 2-aminobenzazepinderivater og deres anvendelse til behandling af immunosuppression
US20040141983A1 (en) 1999-03-15 2004-07-22 Protein Design Labs, Inc. Compositions against cancer antigen LIV-1 and uses thereof
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
US7585326B2 (en) 2004-08-06 2009-09-08 Spinalmotion, Inc. Methods and apparatus for intervertebral disc prosthesis insertion
KR101704734B1 (ko) 2005-07-01 2017-02-09 이. 알. 스퀴부 앤드 선즈, 엘.엘.씨. 예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날 항체
TW201402124A (zh) * 2005-08-19 2014-01-16 Array Biopharma Inc 作為類鐸受體(toll-like receptor)調節劑之8-經取代苯并氮雜呯
CN105669552A (zh) 2009-08-18 2016-06-15 文蒂雷克斯药品公司 作为toll样受体调节剂的取代的苯并氮杂*
CN105669553A (zh) 2009-08-18 2016-06-15 文蒂雷克斯药品公司 作为toll样受体调节剂的取代的苯并氮杂*
CA2793753C (en) 2010-03-26 2018-06-05 Memorial Sloan-Kettering Cancer Center Antibodies to muc16 and methods of use thereof
PT3156420T (pt) 2010-12-06 2019-05-27 Seattle Genetics Inc Anticorpos humanizados a liv-1 e seu uso para tratar o cancro
DK2663555T3 (en) 2011-01-12 2017-03-27 Ventirx Pharmaceuticals Inc SUBSTITUTED BENZOAZEPINS AS MODULATORS OF TOLL-LIKE RECEPTORS
MX346387B (es) 2011-01-12 2017-03-02 Ventirx Pharmaceuticals Inc Benzoazepinas sustituidas como moduladores de receptores tipo toll.
US9034336B2 (en) * 2011-08-30 2015-05-19 Regents Of The University Of Minnesota Immunomodulators and immunomodulator conjugates
US9504756B2 (en) 2012-05-15 2016-11-29 Seattle Genetics, Inc. Self-stabilizing linker conjugates
CN112587671A (zh) 2012-07-18 2021-04-02 博笛生物科技有限公司 癌症的靶向免疫治疗
SG11201605437YA (en) * 2014-01-27 2016-08-30 Pfizer Bifunctional cytotoxic agents
MX378281B (es) 2014-04-25 2025-03-10 Pf Medicament Conjugado farmaco-anticuerpo y su uso para el tratamiento contra el cancer.
CN112546230A (zh) 2014-07-09 2021-03-26 博笛生物科技有限公司 用于治疗癌症的联合治疗组合物和联合治疗方法
CA2970358A1 (en) 2014-12-16 2016-06-23 Celgene Corporation Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof
EP3233835B1 (en) 2014-12-18 2019-01-23 F.Hoffmann-La Roche Ag Benzazepine sulfonamide compounds
CN107231804B (zh) * 2015-01-14 2019-11-26 百时美施贵宝公司 亚杂芳基桥连苯并二氮杂*二聚体、其缀合物及制备和使用方法
HUE042563T2 (hu) * 2015-03-06 2019-07-29 Hoffmann La Roche Benzazepin-dikarboxamid vegyületek
US9943416B2 (en) 2015-03-10 2018-04-17 Simplify Medical Pty Limited Intervertebral spacer that dynamically promotes bone growth
EP3442934A4 (en) 2016-04-13 2019-12-11 Siluria Technologies, Inc. OXIDATIVE COUPLING OF METHANE FOR THE PRODUCTION OF OLEFIN
RS63116B1 (sr) 2016-05-06 2022-05-31 Shanghai De Novo Pharmatech Co Ltd Derivat benzazepina, postupak za dobijanje, farmaceutska kompozicija i njegova upotreba
EP3464274B1 (en) * 2016-05-23 2020-05-27 H. Hoffnabb-La Roche Ag Benzazepine dicarboxamide compounds with secondary amide function
WO2017202704A1 (en) 2016-05-23 2017-11-30 F. Hoffmann-La Roche Ag Benzazepine dicarboxamide compounds with tertiary amide function
EP3468963B1 (en) * 2016-06-12 2021-10-27 F. Hoffmann-La Roche AG Dihydropyrimidinyl benzazepine carboxamide compounds
CA3049791A1 (en) 2017-01-27 2018-08-02 Silverback Therapeutics, Inc. Tumor targeting conjugates and methods of use thereof
EP3576782A4 (en) 2017-02-02 2020-12-30 Silverback Therapeutics, Inc. COMPOSITIONS OF RECOMBINATION PRODUCT-PEPTIDE AND THEIR METHODS OF USE
AU2018236272B2 (en) 2017-03-15 2022-03-31 Silverback Therapeutics, Inc. Benzazepine compounds, conjugates, and uses thereof

Similar Documents

Publication Publication Date Title
AU2022291603B2 (en) Anti-CD123 antibodies and conjugates and derivatives thereof
JP2024059609A5 (cg-RX-API-DMAC10.html)
JP2018511628A5 (cg-RX-API-DMAC10.html)
JP2017186337A5 (cg-RX-API-DMAC10.html)
JP2020534250A (ja) 抗cd8抗体およびその使用
JP2022537151A (ja) 癌の処置のためのネオアジュバント併用療法での活性化可能抗pdl1抗体および抗ctla-4抗体の使用
JP2013529059A5 (cg-RX-API-DMAC10.html)
JP2017506234A5 (cg-RX-API-DMAC10.html)
CA2984639A1 (en) Cd123 antibodies and conjugates thereof
RU2016133846A (ru) Конъюгат лиганд - цитотоксическое лекарственное средство, способ его получения и его применения
JP2021500055A5 (cg-RX-API-DMAC10.html)
JP2020504112A5 (cg-RX-API-DMAC10.html)
TW202304929A (zh) 抗c-Met抗體藥物結合物
JP2020534300A5 (cg-RX-API-DMAC10.html)
US20200206350A1 (en) Compounds for reducing the viscosity of biological formulations
CA3036232A1 (en) Neutralizing antibodies to the .alpha.v.beta.8 integrin complex for immunotherapy
TW201542209A (zh) 癌症之組合療法
TW202333801A (zh) 以結合至191p4d12蛋白質之抗體藥物結合物(adc)治療肌肉侵襲性尿路上皮癌或肌肉侵襲性膀胱癌之方法
JP2022513517A5 (cg-RX-API-DMAC10.html)
JP2022547274A5 (cg-RX-API-DMAC10.html)
JP2016525558A (ja) 結腸直腸ガンの処置に使用するための抗クローディン1抗体
TW202515921A (zh) 抗體-藥物綴合物及其製備方法和用途
CN118591544A (zh) 用于制备抗体药物偶联物的连接子、化合物及用途
WO2026012312A1 (en) Anti-ceacam5 antibody-drug conjugate and method for preparation and use thereof
EP2968539A1 (en) Combination/adjuvant therapy for wt-1-positive disease